- Home
- MODD vs BEAT Comparison
MODD vs BEAT Comparison
Compare MODD & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- BEAT
- Stock Information
- Founded
- MODD 1998
- BEAT 2015
- Country
- MODD United States
- BEAT United States
- Employees
- MODD N/A
- BEAT N/A
- Industry
- MODD Industrial Specialties
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- MODD Health Care
- BEAT Technology
- Exchange
- MODD Nasdaq
- BEAT Nasdaq
- Market Cap
- MODD 46.3M
- BEAT 37.7M
- IPO Year
- MODD N/A
- BEAT 2021
- Fundamental
- Price
- MODD $0.73
- BEAT $1.41
- Analyst Decision
- MODD
- BEAT Buy
- Analyst Count
- MODD 0
- BEAT 1
- Target Price
- MODD N/A
- BEAT $8.00
- AVG Volume (30 Days)
- MODD 1.2M
- BEAT 78.2K
- Earning Date
- MODD 11-13-2025
- BEAT 11-06-2025
- Dividend Yield
- MODD N/A
- BEAT N/A
- EPS Growth
- MODD N/A
- BEAT N/A
- EPS
- MODD N/A
- BEAT N/A
- Revenue
- MODD N/A
- BEAT N/A
- Revenue This Year
- MODD N/A
- BEAT N/A
- Revenue Next Year
- MODD N/A
- BEAT $19.35
- P/E Ratio
- MODD N/A
- BEAT N/A
- Revenue Growth
- MODD N/A
- BEAT N/A
- 52 Week Low
- MODD $0.63
- BEAT $0.91
- 52 Week High
- MODD $2.50
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- MODD 50.78
- BEAT 59.24
- Support Level
- MODD $0.65
- BEAT $1.30
- Resistance Level
- MODD $1.00
- BEAT $1.39
- Average True Range (ATR)
- MODD 0.07
- BEAT 0.11
- MACD
- MODD 0.00
- BEAT 0.01
- Stochastic Oscillator
- MODD 20.55
- BEAT 61.05
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.